Methodology · Raw JSON · Last updated 2026-05-08
Pharmacy M&A Multiples — $500M+ EV
Median, p25, and p75 EV/EBITDA and EV/Revenue multiples from publicly- disclosed acquisitions in this size bracket, 2018-2026.
Headline numbers
| Metric | p25 | Median | p75 | n |
|---|---|---|---|---|
| EV/EBITDA | 12.2x | 19.75x | 21.07x | 16 |
| EV/Revenue | 0.2x | 1x | 2.08x | 10 |
What's your Pharmacy business worth?
Get an instant valuation range for your business. Backed by 25,592 real M&A transactions.
What this answers
What is the median EV/EBITDA multiple for a Pharmacy acquisition in the $500M+ EV bracket?
19.75x EV/EBITDA, based on n=16 disclosed transactions (2018-2026). The interquartile range is 12.2x-21.07x.
What is the median EV/Revenue multiple for a Pharmacy acquisition in the $500M+ EV bracket?
1x EV/Revenue, based on n=10 disclosed transactions (2018-2026). The interquartile range is 0.2x-2.08x.
Where does this data come from?
Publicly-disclosed M&A transactions filed with the SEC (8-K, S-4 fairness opinions) plus verified press releases. No estimated, imputed, or licensed data. Each cell requires n≥10 to publish. See https://exitvalue.ai/methodology for the full sourcing rules.
How current is this data?
Source window: 2018-2026. Refreshed weekly as new SEC filings accumulate. Last published: 2026-05-08.
Other size brackets for Pharmacy
How to cite: ExitValue.ai. (2026). Pharmacy M&A Multiples ($500M+ EV). https://exitvalue.ai/stats/pharmacy-over-500m-ev-multiples
License: CC-BY 4.0 (data) / MIT (code). Attribution required.
Want a valuation for your specific business? Run the calculator →